Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuchimanchi

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Highly effective non-explosive activators based on saccharin for the synthesis of oligonucleotides and phosphoramiditesNanda D Sinha, Patrick Foster, Satya N Kuchimanchi, et al.
Annals of Maxillofacial Surgery|August 6, 2025
Ethnic Deviation of Northeastern Andhra Population from Standard Cephalometrics for Orthognathic Surgery - A Comparative StudySreesai Mummareddy, Phani Kumar Kuchimanchi, Nagamalleswara Rao Inturi, et al.
Nucleic Acid Therapeutics|December 7, 2016
Impact of Oligonucleotide Structure, Chemistry, and Delivery Method on In Vitro CytotoxicityMaja M Janas, Yongfeng Jiang, Mark K Schlegel, et al.
Cancer Chemotherapy and Pharmacology|September 28, 2010
Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patientsJian-Feng Lu, Laurent Claret, Liviawati Sutjandra, et al.
The Journal of Contemporary Dental Practice|February 14, 2013
Evaluation of knowledge and experience among oral and maxillofacial surgeons about cardiopulmonary resuscitationSuprakash Boddu, Raja Satish Prathigudupu, Anand Vijay Somuri, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 9, 2018
Population pharmacokinetics and exposure-response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemiaMita Kuchimanchi, Anita Grover, Maurice G Emery, et al.
Chemical Research in Toxicology|April 1, 1996
Improved strategies for postoligomerization synthesis of oligodeoxynucleotides bearing structurally defined adducts at the N2 position of deoxyguanosineB L DeCorte, D Tsarouhtsis, S Kuchimanchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 18, 2009
In vitro metabolism of the novel, highly selective oral angiogenesis inhibitor motesanib diphosphate in preclinical species and in humansChun Li, Mita Kuchimanchi, Dean Hickman, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Differential Pharmacokinetics of Ganitumab in Patients With Metastatic Pancreatic Cancer Versus Other Advanced Solid CancersMin Zhu, Nathalie H Gosselin, Mita Kuchimanchi, et al.
Annals of Surgery|August 4, 2025
Where You Train Matters: Surgeon-Scientists Disproportionately Trained at Highly Funded InstitutionsMackenzie M Mayhew, Nidhi Kuchimanchi, Justin Lee, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Nucleosides, Nucleotides & Nucleic Acids|December 11, 2007
Highly effective non-explosive activators based on saccharin for the synthesis of oligonucleotides and phosphoramiditesNanda D Sinha, Patrick Foster, Satya N Kuchimanchi, et al.
Annals of Maxillofacial Surgery|August 6, 2025
Ethnic Deviation of Northeastern Andhra Population from Standard Cephalometrics for Orthognathic Surgery - A Comparative StudySreesai Mummareddy, Phani Kumar Kuchimanchi, Nagamalleswara Rao Inturi, et al.
Nucleic Acid Therapeutics|December 7, 2016
Impact of Oligonucleotide Structure, Chemistry, and Delivery Method on In Vitro CytotoxicityMaja M Janas, Yongfeng Jiang, Mark K Schlegel, et al.
Cancer Chemotherapy and Pharmacology|September 28, 2010
Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patientsJian-Feng Lu, Laurent Claret, Liviawati Sutjandra, et al.
The Journal of Contemporary Dental Practice|February 14, 2013
Evaluation of knowledge and experience among oral and maxillofacial surgeons about cardiopulmonary resuscitationSuprakash Boddu, Raja Satish Prathigudupu, Anand Vijay Somuri, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 9, 2018
Population pharmacokinetics and exposure-response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemiaMita Kuchimanchi, Anita Grover, Maurice G Emery, et al.
Chemical Research in Toxicology|April 1, 1996
Improved strategies for postoligomerization synthesis of oligodeoxynucleotides bearing structurally defined adducts at the N2 position of deoxyguanosineB L DeCorte, D Tsarouhtsis, S Kuchimanchi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 18, 2009
In vitro metabolism of the novel, highly selective oral angiogenesis inhibitor motesanib diphosphate in preclinical species and in humansChun Li, Mita Kuchimanchi, Dean Hickman, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Differential Pharmacokinetics of Ganitumab in Patients With Metastatic Pancreatic Cancer Versus Other Advanced Solid CancersMin Zhu, Nathalie H Gosselin, Mita Kuchimanchi, et al.
Annals of Surgery|August 4, 2025
Where You Train Matters: Surgeon-Scientists Disproportionately Trained at Highly Funded InstitutionsMackenzie M Mayhew, Nidhi Kuchimanchi, Justin Lee, et al.
Pageof 8